Biohit

Keskustelua kotimaisista osakkeista.

Valvoja: Ram

Re: Biohit

ViestiKirjoittaja tunakalastaja » 20.10.2017 12:23

Nimenomaan näin ja sitä yritin selittää!
Kun riskiryhmät löydetään tehdään veritesti (GP) jos jotain poikkeavaa niin seuraavaksi skopia, jos kaikki on hyvin niin uusi veritesti kahden vuoden välein, aikamoinen "raha-automaatti" jollekin:)

Tuosta patentista mikä myönnetty elokuussa, sattumaa tai ei mutta yhteisyritys tiedotti jotain patentti ja lupajuttuja juuri samaan aikaan!
  • 0

tunakalastaja
 
Viestit: 114
Liittynyt: 18.08.2015 10:31
Reputation: 1

Re: Biohit

ViestiKirjoittaja Timbo » 20.10.2017 12:25

Teksteistä ei voi päätellä tarkoitetaanko "neljän funktion testillä" Gastropanelia vai PGI, PGII, PGR ja Hp. Molempia on kutsuttu tällä nitmiyksellä.

PGI, PGII, PGR, Hp on kilpaileva tuote GP:lle.

Kilpaileva tuote Mokosensro-A300 colloidal gold immunoassay: http://news.pharmnet.com.cn/news/2014/06/05/398603.html

Tässä puhutaan GP:stä neljän funktion testinä: http://www.sdrmyy.com/Item/11633.aspx
  • 0

Timbo
 
Viestit: 134
Liittynyt: 27.02.2014 07:45
Reputation: 1

Re: Biohit

ViestiKirjoittaja tunakalastaja » 20.10.2017 13:31

On vielä neljäskin!
PGl, PGll, PGR, G-17

Tuossa sinun aikaisemmin linkittämässä puhuttiin että helico testi otetaan ensin! Voi tietenkin olla käännöskukkanen mutta jos ei niin silloin tämä Hitin sopisi parhaiten!
Hitillä Kiinan valikoimissa tietenkin myös normi GP mutta tässä mikä tarkoitettu (käsittääkseni) seulontoihin ei ole helicoa mukana!

http://www.biohithealthcare.com.cn/prod ... ex_34.aspx

Nämä kolme uutta kokonaisuutta voivat myös selittää miksi Kiinassa kestää! Halutaan verrata mikä näistä kolmesta soveltuu parhaiten, joko kaikille tai mikä minkäkin kokoiselle sairaalalle?
  • 0

tunakalastaja
 
Viestit: 114
Liittynyt: 18.08.2015 10:31
Reputation: 1

Re: Biohit

ViestiKirjoittaja Akseli Gran » 29.10.2017 08:25

Nyt on minulla tankkauset tämän osalta päättyneet näin oletan. Mutta takinkäännökset on minulla tosi nopeita.

Jos edes pikkiriikkinen osa menee Lohenkalastajan aatoksen mukaan niin nousu ollee tosi reipas.
Tässä KLn palstalta kopsattu
  • 0

Liitteet
ScreenHunter_1203 Oct. 29 08.13.jpg
ScreenHunter_1203 Oct. 29 08.13.jpg (100.37 KiB) Katsottu 855 kertaa
Akseli Gran
 
Viestit: 552
Liittynyt: 30.05.2014 05:21
Reputation: 20

Re: Biohit

ViestiKirjoittaja Timbo » 31.10.2017 09:00

Toivottavasti Hefei on tässä mukana GP:llä:

http://health.rednet.cn/c/2017/10/31/4461004.htm

"5 years for 5 million residents free screening cancer
...
Cancer early diagnosis and treatment project by the State Health Commission, Bureau of Disease Control and Prevention in 2012 started, Changsha City, Hunan is the only project implementation of the city, to carry out the project 5 years for the city's 22 million urban residents free cancer risk assessment, More than 50,000 high-risk groups were screened, a total of cancer (suspected cancer) nearly 400 cases, found that the stomach, intestine and other parts of precancerous lesions more than 4700 cases, so that these patients get early intervention and treatment opportunities.

Changsha City CDC reminded, 2017-2018 urban cancer early diagnosis and treatment project is about to start, Furong District, Tianxin District, Yuelu District, Kaifu District and Yuhua District, District 5 resident population (in the local residence of more than 3 years) , And the age of 40-69 years old people can apply for free screening.
...
According to statistics, lung cancer, breast cancer, colorectal cancer, upper gastrointestinal cancer (including gastric cancer and esophageal cancer) and liver cancer is the most common malignancy in China, accounting for about 66% of all new cases of cancer. China since 2005 in rural areas with high incidence of cancer to carry out a variety of early diagnosis and treatment of cancer early work, to obtain a wealth of practical experience, starting in 2012, the State Health Commission, Bureau of Disease Control and Prevention led the city early onset of cancer early treatment project. The project is mainly for the above five categories of a total of six kinds of cancer risk assessment, screening and early diagnosis and treatment, screening costs free."
  • 0

Timbo
 
Viestit: 134
Liittynyt: 27.02.2014 07:45
Reputation: 1

Re: Biohit

ViestiKirjoittaja Timbo » 31.10.2017 10:00

En saa selvää kuka on voittanut ja mitä, mutta GP:iin liittyvä projekti mainittu:

http://www.cdgrlyy.org/showns/showns201 ... 23860.html

"Sichuan Provincial People's Hospital Health Management Center won the outstanding task force recognition

China Health Promotion Foundation Deputy Secretary-General and Director of Health Management, Chinese Medical Association Health Management Branch Standing Committee and Secretary-General Chen Gang read "read the recognition of multi-center application research project decision." The meeting of the three units of the application of more than 100 units of the multi-center group were commended, three topics were the national health check-up crowd Helicobacter pylori screening multi-center study Phase II intervention, early warning of stroke and cerebrovascular health management Study on multi - center application of gastrin 17 combined with pepsinogen in early gastric cancer screening and risk assessment.

In recent years we actively advocate and vigorously promote the health management "ten, one hundred thousand" project. Which multi-center application research is the core content. Whether the project implementation unit can enter the 100 is an important stage of research, the establishment of large data on the subject, to a wider range of promotion, is of great significance."
  • 0

Timbo
 
Viestit: 134
Liittynyt: 27.02.2014 07:45
Reputation: 1

Re: Biohit

ViestiKirjoittaja Timbo » 31.10.2017 15:58

GP:lle löytyy myös kilpailijoita. Tässä tutkittu 2014-2016 välisenä aikana miten pelkillä pepsinogeeneillä pystytään tunnistamaan vatsasairauksia. Joku asiantuntija voisi kommentoida tarkemmin tuloksia.

http://www.chinaqking.com/yc/2017/938167.html

"Application of Gastric Function Detection in Gastric Diseases

(Jingjiang People's Hospital, Jingjiang, Jiangsu 214500, China)
[Abstract] Objective: To explore the application of gastric function in gastric disease. Methods: The clinical data of 240 patients with various stomach diseases were analyzed retrospectively from January 2014 to December 2016. At the same time, 200 cases of negative gastroscopy were selected as the control group. The PGI, PGII and PG I / PG II. Results: Compared with the control group, the levels of PGI and PG I / PG II in patients with chronic atrophic gastritis and gastric cancer were significantly decreased (P <0.05); serum PGI, PGII and PGI in patients with gastric ulcer and duodenal ulcer / PG II was significantly higher than the control group, the difference was statistically significant (P <0.05). Conclusion: The changes of serum PG level and its ratio have some guiding significance for the early screening of gastric diseases, which deserves clinical attention.
...
1. Materials and methods

1.1 General information
The clinical data of 240 patients with various stomach diseases were analyzed retrospectively from January 2014 to December 2016, including 155 males and 85 females with an average age of (56.4 ± 5.3) years. At the same time, 200 cases of negative gastroscopy were selected as the control group, including 130 cases of male and 70 cases of female, the average age (55.3 ± 4.6) years. There was no statistically significant difference in age and sex ratio between the two groups (P> 0.05).

1.2 serum pepsinogen detection method
All patients were in the morning fasting state by the professional collection of venous blood about 3mL, after standing to separate the serum, -20 ℃ preservation to be measured. Serum levels of PGI and PG II were measured by enzyme-linked immunosorbent assay (ELISA). The kit was purchased from Beijing Jiujiang Biotechnology Co., Ltd., by professional inspection personnel in strict accordance with the operating instructions.

1.3 Statistical Methods
All data analysis in the professional statistical software SAS 9.0 software package, the two groups of patients with the measurement index (mean ± standard deviation), compared with the t test; count data using percentage (%), Line chi-square test. P <0.05 represents the difference between the two groups was statistically significant.

2. Results
2.1 Comparison of serum PGI, PGII and PGI / PGII levels between healthy controls and different stomach groups Compared with the control group, the levels of PGI and PG I / PG II in patients with chronic atrophic gastritis and gastric cancer were significantly decreased (P <0.05). The levels of PGI, PGII and PG I / PG II in patients with gastric ulcer and duodenal ulcer were significantly higher than those in control group (P <0.05). See Table 1.
  
3 Discussion

In recent years, the stomach disease seriously affected the human body and mind health, China is a particularly high incidence of gastric cancer, the diagnosis and treatment situation has been not optimistic [3]. The results showed that the survival rate of gastric cancer in different periods was different, and the survival rate of early gastric cancer patients was 90% after treatment. Therefore, early detection and diagnosis and treatment have become the only way to improve the survival rate of gastric cancer [4]. At present, endoscopy and pathological biopsy are still regarded as the "gold standard" for diagnosing gastropathy, but neither of the two diagnostic methods can be widely used as a census. In recent years, domestic and foreign clinical workers have begun through the determination of serum pepsinogen for gastropathy screening and implementation of gastric cancer prevention intervention plan [5].
In recent years, many clinical studies have shown that serum PG levels and a variety of stomach disease is closely related to the occurrence and development, such as Helicobacter pylori infection stomach, peptic ulcer, atrophic gastritis, portal hypertensive gastropathy and gastric cancer [6] The In this study, we found that serum PGI and PG I / PG II ratios were significantly lower in patients with chronic atrophic gastritis and gastric cancer compared with the normal control group, and PG II levels were not significantly altered due to atrophic gastritis and Gastric cancer patients with gastric mucosal secretion decreased significantly; and gastric ulcer and duodenal ulcer patients with serum PGI, PGII and PGI / PG II was significantly higher than the normal control group, which may be due to ulcers and inflammation of the stress State, PG will compensate for increased secretion, and PG Ⅰ increased more significant; the results of this study and Le Yan et al's findings are consistent [7].

Based on the above analysis, we believe that the level of serum PG and its ratio changes in the early screening of gastric diseases have some guiding significance, worthy of clinical attention. "
  • 0

Timbo
 
Viestit: 134
Liittynyt: 27.02.2014 07:45
Reputation: 1

Re: Biohit

ViestiKirjoittaja Timbo » 01.11.2017 16:05

Shubang otsikoissa jälleen - hyvin ovat kinuskit omineet tuotteen: :lol:

http://news.ifengyo.com/rt-channel/rtli ... /7070.html

"CCTV concern - China's pharmaceutical innovation, the interview with the big Shu Bang
...
With the support of national policies and government resources, the pharmaceutical industry in recent years, vigorous development, there are some innovative cases. In 2015, China's anti-cancer drugs to break the foreign monopoly, independent research and development of anti-cancer drug - Xindaben amine, and approved the global market, greatly reducing the cost of treatment of cancer patients. In 2016, the great medicine also launched one of the innovative initiatives, cutting-edge liver protection hangover - "Shu Bang brand L-cysteine ​​capsules." These inventions have become an important milestone in the development of Chinese medicine towards independent innovation.

In the country to encourage pharmaceutical innovation under the guidance of the policy, the great medicine as the old pharmaceutical companies continue to strive to introduce high-tech talent, through independent research and innovation to successfully break the foreign technology blockade, in the biological agents to refresh the four national standards, eight industry standards, Is similar to Shu Bang licensing L-cysteine ​​capsules mass production, so that the great medicine from raw material manufacturing exports to the industrial chain in depth development of the transition from "Made in China" to "China Zhi-made" the successful transformation.

The great innovation of the pharmaceutical industry has also aroused great concern of the national media, during the nineteenth period, CCTV news center for the pharmaceutical innovation plate, in particular, went to Wuhan interview executive director of the Hubei Provincial Medicine Association and the leader of the large medical and bio-plate Mr. Qian Zhiqiang. In accepting CCTV news interview Qian Zhiqiang said: "Great medicine in the active implementation of the international quality system, the quality of international standards and quality management personnel of the internationalization is precisely through these measures to fully drive the great medicine in independent research and innovation Breakthrough in the field, effectively breaking the foreign technology blockade, and constantly refresh the national and industry standards."
  • 0

Timbo
 
Viestit: 134
Liittynyt: 27.02.2014 07:45
Reputation: 1

Re: Biohit

ViestiKirjoittaja Timbo » 01.11.2017 16:17

Ja lisää Shubangista. Ylistyssanoja aika paljon. Puhutaan myös patentoinnista.

http://www.dzshbw.com/news/2017/shangye_1101/75830.html

"Chutian Jingwei dialogue Shu Bang to promote Chinese products to the Chinese brand change

Grand Shu Bang since the market, praise constantly, good news again and again. Following the development of China's new health medicine retail new channels, but also as a business card, the Chinese brand landing Wuhan Tianhe Airport T3-terminal, but also unveiled the New York Times Square large screen to China's "wisdom" made the attitude of the world.

Accordingly, Hubei local influential Hubei education channel "Chutian Jingwei" column group, made a special trip to the Great Shu Bang conducted a series of in-depth coverage. This section was launched in 2004 and is a television program that has been launched for more than a decade following the Hubei News Network. It provides information and services related to cultural life and economy to the audience. This time, the column group focus on the big Shu Bang, one to the principle of drunken drunk hang wine, advocate healthy drinking new fashion; second to the general public friends in detail and comprehensive introduction from Wuhan ambitious independent research and development of the forefront of new drugs - "Shubang brand L-cysteine ​​capsules".

At present, China's large health industry is in a wave of vigorous development, ambitious medicine to a solid scientific research and technology, developed a chemical liver injury with auxiliary protection of health care products. The product involved in the production technology by the national patent protection, with the State Intellectual Property Office issued the "invention patent specification", is the innovation of China's biotechnology strength of another masterpiece! In addition to the production of relying on the excellent technology, marketing , Great Shu Bang also made a lot of bold attempts. For example, the laying of online and offline full-channel operation strategy, together today convenience stores, Rosen convenience stores and a large chain of large pharmacy, opened Jingdong, Lynx, Amazon, WeChat Mall and other business platform and so on. All the exploration and innovation, are designed to provide a better purchase experience for the people.

In the country to encourage pharmaceutical innovation under the guidance of the policy, the great medicine as a red pharmaceutical companies, continuous efforts to blaze new trails, launched a number of innovative initiatives, not only for the Hubei biotechnology industry cluster transformation and follow-up development of a number of feasibility New ideas, so that Hubei health consumption index increased significantly. At the same time, in the fast opening of the market situation is also the focus of forging a considerable amount of gold in Hubei business card.

Grand Chubang first in the country to promote national health drinking a new way to lead the liver health upgrade. From the survey in 2011, China is a high incidence of liver cancer, the current annual about 320,000 cases of liver cancer patients died, of which 58% of liver cancer is drinking out. In such a grim form, the big Shu Bang bear the responsibility of cultivating people's healthy drinking habits, is committed to reverse the people of non-healthy drinking do not understand the status quo, to provide medical solution of the medical solution, personally fulfilled the great medicine has been adhering to The "world", the health of the big "corporate philosophy, and will unswervingly uphold the spirit, and actively participate in the health industry at home and abroad, and constantly groundbreaking attempts and exploration, help" Chinese products "into "Chinese brand"!"
  • 0

Timbo
 
Viestit: 134
Liittynyt: 27.02.2014 07:45
Reputation: 1

Re: Biohit

ViestiKirjoittaja Timbo » 02.11.2017 21:32

Toinen kilpailija GP:lle löydetty. Se on sitten toinen asia, että kenen laariin tämä loppujen lopuksi sataa, että nämä pepsinogeenitestit yleistyvät syöpäseulonnoissa.

http://www.xinjiangnet.com.cn/2017/1101/2015261.shtml

"Early screening of gastric cancer diagnosis seminar

In order to improve the hospital medical staff's medical diagnosis and treatment, timely update medical knowledge, and better serve the majority of patients. At the same time continue to expand our hospital physical examination in the business areas for the general public to do health management services. On October 18, our hospital invited Dr. Zhang Feng from PLA Academy of Military Medical Sciences and experts from Shenzhen Meikang Biotech Co., Ltd. to conduct a systematic lecture on "Early Screening Diagnosis of Gastric Cancer" in our hospital.

The lecture focuses on the latest detection of gastric cancer early screening means - pepsinogen determination, which in the early screening of gastric cancer specificity and high sensitivity, has important diagnostic value, is the world's newest gastric cancer One of the means of screening.

Through this lecture, everyone benefits a lot. We are fully aware of the effective means of fighting cancer is early prevention, early screening, early diagnosis, early treatment. Advocate the people of all ages at all levels of the community to conduct targeted and focused medical examination on a regular basis, maintain good health conditions, and better serve the community and reflect personal values."

---

Tässä vielä tietoa ko yrityksestä. Ei ole mikään nakkikiska vaan on listautunut Shenzhenin pörssiin. MC on jos oikein tulkitsin niin 1 Mrd€...

https://www.bloomberg.com/quote/300439:CH
http://www.nb-medicalsystem.com/alone/alone.php?id=62
  • 0

Timbo
 
Viestit: 134
Liittynyt: 27.02.2014 07:45
Reputation: 1

EdellinenSeuraava

Paluu Kotimaiset osakkeet

Paikallaolijat

Rekisteröityneet käyttäjät:
Bing [Bot]
Reputation System ©'